Philip Dawdy
ddobbs | June 25, 2009Much much much ado on the web this week, on the too-many fronts I try to visit. From my list of notables:
Carl Zimmer, who clearly doesn't sleep, writes up a nice post about a Nature paper announcing Limusaurus, a newly discovered fossil that is, Zimmer notes, is "not -- I repeat NOT -- the missing link between anything"-- but nevertheless sheds some light on how dinos may have turned into birds (more or less). Bonus: Great pictures of Carl holding up three fingers.
Ed Yong, who seems to be drinking the same strength coffee as Carl Zimmer lately, looks at an interesting correlation: Hidden…
ddobbs | March 5, 2009Philip Dawdy takes a interesting look at a new study of the safety of placebo arms in clinical trials of antidepressants in teens. My own quick scan of the study [which Dawdy makes available as pdf download] suggests it's full of great nuggets.
Its take-home: Placebo treatments produced remission rates of 48%, while the rate for active treatment was 59%. And, quite interestingly, the study concludes:
Patients who responded to placebo generally retained their response. Those who did not respond to placebo subsequently responded to active treatment at the same rates as those initiallyl…
ddobbs | January 22, 2009
In response to my post on himself, the NY Times, Zyprexa, Infinite Mind, etc.
ddobbs | January 19, 2009I stirred some ire last week when I asserted that the Times (for -- disclosure dept -- whom I sometimes write) and similar mainstream papers offer a public good through their unique combination of a) access to information and 2) clout with the public and government. Several readers took me to task (see the comments section of the post linked above), arguing that these papers have failed their public mission by dropping the ball several times lately, most notably during the run-up to the Iraq War. "Let the dinosaur die," is the argument. In a similar vein, some science bloggers (see this post…